ArticleNeurology and therapy2022

Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.

Anne H Cross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.